Oncology Net Debt from 2010 to 2026

TOIIW Stock

USD 0.10 0.01 9.09%

Oncology Institute Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2026. Net Debt is the total debt of The Oncology Institute minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2020-03-31

Previous Quarter

73.3 M

Current Value

-302 K

Quarterly Volatility

59.9 M

Covid

Interest Hikes

Check Oncology Institute financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncology Institute's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 4.3 M or Interest Expense of 9.1 M, as well as many indicators such as Price To Sales Ratio of 0.0644, Dividend Yield of 0.0105 or PTB Ratio of 9.87. Oncology financial statements analysis is a perfect complement when working with Oncology Institute Valuation or Volatility modules.

Build AI portfolio with Oncology Stock

Check out the analysis of Oncology Institute Correlation against competitors.

For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.

The evolution of Net Debt for The Oncology Institute provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Oncology Institute compares to historical norms and industry peers.

Latest Oncology Institute's Net Debt Growth Pattern

Below is the plot of the Net Debt of The Oncology Institute over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Oncology Institute's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oncology Institute's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Oncology Net Debt Regression Statistics

	Arithmetic Mean	17,319,304
	Coefficient Of Variation	305.28
	Mean Deviation	40,056,312
	Median	(2,446,201)
	Standard Deviation	52,872,636
	Sample Variance	2795.5T
	Range	208.3M
	R-Value	0.54
	Mean Square Error	2113.7T
	R-Squared	0.29
	Significance	0.03
	Slope	5,649,569
	Total Sum of Squares	44728.2T

Oncology Net Debt History

	2026	88.7 M
	2025	84.5 M
	2024	73.5 M
	2023	86.2 M
	2022	94.2 M
	2021	-114.1 M
	2020	5.9 M

Other Fundumenentals of The Oncology Institute

Net Debt To E B I T D A

Oncology Institute Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Intangible Assets	Common Stock	Current Deferred Revenue	Long Term Debt	Short Long Term Debt	Short Term Debt
Total Assets		0.32	0.5	-0.75	0.61	0.85	0.07	0.92	0.98	0.97	-0.92	0.96	-0.82	0.89	-0.28	0.95	-0.97	-0.04
Total Stockholder Equity	0.32		-0.32	0.37	-0.42	-0.15	0.81	-0.04	0.37	0.25	-0.16	0.4	0.25	0.01	-0.88	0.06	-0.13	-0.6
Net Debt	0.5	-0.32		-0.66	0.43	0.75	-0.64	0.63	0.55	0.39	-0.47	0.29	-0.61	0.51	0.31	0.53	-0.5	0.79
Retained Earnings	-0.75	0.37	-0.66		-0.9	-0.92	0.48	-0.92	-0.69	-0.79	0.78	-0.67	0.97	-0.89	-0.28	-0.89	0.87	-0.33
Accounts Payable	0.61	-0.42	0.43	-0.9		0.85	-0.46	0.85	0.53	0.69	-0.66	0.53	-0.9	0.81	0.36	0.81	-0.73	0.29
Net Receivables	0.85	-0.15	0.75	-0.92	0.85		-0.43	0.98	0.83	0.83	-0.83	0.72	-0.92	0.88	0.12	0.93	-0.88	0.43
Good Will	0.07	0.81	-0.64	0.48	-0.46	-0.43		-0.29	0.05	0.03	0.06	0.18	0.31	-0.15	-0.57	-0.15	0.06	-0.87
Total Liab	0.92	-0.04	0.63	-0.92	0.85	0.98	-0.29		0.88	0.92	-0.89	0.83	-0.94	0.94	0.0	0.98	-0.95	0.25
Net Invested Capital	0.98	0.37	0.55	-0.69	0.53	0.83	0.05	0.88		0.93	-0.93	0.93	-0.75	0.81	-0.32	0.91	-0.93	0.03
Total Current Assets	0.97	0.25	0.39	-0.79	0.69	0.83	0.03	0.92	0.93		-0.93	0.98	-0.84	0.92	-0.28	0.97	-0.98	-0.12
Capital Stock	-0.92	-0.16	-0.47	0.78	-0.66	-0.83	0.06	-0.89	-0.93	-0.93		-0.91	0.81	-0.77	0.12	-0.94	0.96	0.01
Net Working Capital	0.96	0.4	0.29	-0.67	0.53	0.72	0.18	0.83	0.93	0.98	-0.91		-0.73	0.83	-0.42	0.91	-0.94	-0.26
Intangible Assets	-0.82	0.25	-0.61	0.97	-0.9	-0.92	0.31	-0.94	-0.75	-0.84	0.81	-0.73		-0.93	-0.25	-0.93	0.9	-0.23
Common Stock	0.89	0.01	0.51	-0.89	0.81	0.88	-0.15	0.94	0.81	0.92	-0.77	0.83	-0.93		-0.07	0.93	-0.92	0.08
Current Deferred Revenue	-0.28	-0.88	0.31	-0.28	0.36	0.12	-0.57	0.0	-0.32	-0.28	0.12	-0.42	-0.25	-0.07		-0.07	0.13	0.54
Long Term Debt	0.95	0.06	0.53	-0.89	0.81	0.93	-0.15	0.98	0.91	0.97	-0.94	0.91	-0.93	0.93	-0.07		-0.99	0.08
Short Long Term Debt	-0.97	-0.13	-0.5	0.87	-0.73	-0.88	0.06	-0.95	-0.93	-0.98	0.96	-0.94	0.9	-0.92	0.13	-0.99		0.01
Short Term Debt	-0.04	-0.6	0.79	-0.33	0.29	0.43	-0.87	0.25	0.03	-0.12	0.01	-0.26	-0.23	0.08	0.54	0.08	0.01

Click cells to compare fundamentals

About Oncology Institute Financial Statements

Oncology Institute investors use historical fundamental indicators, such as Oncology Institute's Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Oncology Institute. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	84.5 M	88.7 M
Net Debt To EBITDA	(1.23)	(1.29)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

Additional Tools for Oncology Stock Analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Oncology Net Debt from 2010 to 2026

Latest Oncology Institute's Net Debt Growth Pattern

Oncology Net Debt Regression Statistics

Oncology Net Debt History

Other Fundumenentals of The Oncology Institute

Oncology Institute Net Debt component correlations

About Oncology Institute Financial Statements

Also Currently Popular

Additional Tools for Oncology Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY